secwatch.observer — SEC 8-K summary
======================================

Issuer:     NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC)
CIK:        0001500198
Form:       8-K
Filed at:   2023-03-17T23:59:59+00:00
Accession:  0001213900-23-021037
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

NeuroOne holds annual meeting; elects directors Mathiesen and Andrle, ratifies auditor
--------------------------------------------------------------------------------

- Annual meeting held March 16, 2023; 9,719,474 shares (59.83%) represented.
- Jeffrey Mathiesen re-elected as Class III director: 4,309,601 votes for, 268,402 withheld.
- Edward Andrle re-elected as Class III director: 3,474,438 votes for, 1,103,565 withheld.
- Baker Tilly U.S., LLP ratified as independent auditor for FY ending Sept 30, 2023: 9,661,674 for, 45,763 against, 12,037 abstain.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1500198/000121390023021037/0001213900-23-021037-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1500198/000121390023021037/ea175425-8k_neuroone.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-021037

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer